BPH

Prostatic urethral lift (UroLift) placement under topical anesthesiaThis video demonstrates UroLift placement under topical anesthesia in the office setting and also includes comments from several patients who underwent the procedure.
Prostatic urethral lift (UroLift): A minimally invasive approachThis video provides an overview of the prostatic urethral lift (UroLift), highlighting the entire cycle of patient care.
Water ablation’s safety, efficiency in BPH assessedAn image-guided technique for treating LUTS associated with BPH is reproducible and promising, researchers say.
AUA 2016: Experts offer guidance on the meetingTo guide you through the 2016 AUA annual meeting and help maximize your time, Urology Times’ editorial board has reviewed the program to identify the key trends and noteworthy research at this year’s meeting.
Uro Pipeline: FDA grants priority review to advanced bladder Ca agentAlso look for coverage of products in the pipeline for bladder pain syndrome/interstitial cystitis, prostate cancer, and male infertility.
Uro Pipeline: 1st patients treated in phase III study of investigational BPH TxOther pipeline products discussed in this article include an immunotherapy for metastatic bladder cancer, a treatment for lower urinary tract symptoms of BPH, and an investigational clear cell renal cell carcinoma treatment.
Study: BPH procedure’s benefits sustained at 3 yearsThe prostatic urethral lift (PUL [UroLift, NeoTract, Inc.]) yields successful 3-year durability and superior rate of improvement of BPH symptoms compared to transurethral resection of the prostate, according to separate studies presented at the AUA annual meeting in New Orleans.
BPH modality may offer efficient optionA novel treatment for the targeted removal of prostate tissue may soon be coming to a hospital near you. According to the results of a phase II study presented at the AUA annual meeting in New Orleans, Aquablation, a minimally invasive water ablation therapy, demonstrated efficient and precise resection of prostate tissue in patients with BPH.
Convective transurethral therapy reduces LUTSA handheld transurethral therapy that delivers targeted sterile water vapor reduces lower urinary tract symptom severity in patients with BPH with no impact on sexual function.
New tech may bring exciting era in BPHThe management of BPH has had an interesting roller coaster ride over the past 25 years with new medicines, minimally invasive surgical therapies, and a host of novel surgical technologies, including lasers and bipolar electrosurgery.